Quality of the Cardio-pulmonary Resuscitation

NCT ID: NCT05250453

Last Updated: 2022-02-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-01

Study Completion Date

2023-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients having sudden cardiac arrest have very poor prognosis. It is devastating for patient and family. But also very expensive for nations economics when working-age people die or disable due to cardiac arrest. Recent studies have shown that high quality of cardiopulmonary resuscitation (CPR) and minimized delays increases the survival after cardiac arrest. In this objective prospective study we will use Zoll´s X Series defibrillator on every emergency medicine systems (EMS´s) unit in Pirkanmaa area, Finland, to collect information on CPR quality. Real CPR Help® will collect the information on depth, frequency and pauses during CPR. We will make an Utstein analysis on OHCA during one year period and compare the results on Utstein analysis made in the same area on 2013-2014. We will analyse the quality of CPR and compare it to the outcome from OHCA and neurological outcome 3 months after resuscitation. In addition we will analyse the CPR related injuries and compare these to the compression depth and number of persons performing CPR.

In one part of the study we will evaluate the incidence of OHCA in different risk areas of Pirkanmaa and analyse the influence of time delay and location to the outcome out of hospital and neurological outcome 3 months after resuscitation. We will also analyse if the time of post-resuscitation care before getting to the hospital or stenosis in carotid artery affects the outcome from OHCA and neurological outcome 3 months after resuscitation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiopulmonary Resuscitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cardiac arrest

All patients having sudden cardiac arrest out-of-hospital in Pirkanmaa, Finland

No interventions assigned to this group

ResusInj

OHCA survivors having CPR related injuries or carotid stenosis analyzed by CT

No interventions assigned to this group

ResusCPC

OHCA survivors neurological outcome

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* cardiac arrest
* \> 18 years of age

Exclusion Criteria

* \< 18 years of age
* prisoners
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Istitute For Health and Welfare, Finland

OTHER_GOV

Sponsor Role collaborator

Tampere University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Piritta Setälä, PhD

Role: STUDY_DIRECTOR

Tampere University Hospital

Sanna Hoppu, PhD

Role: STUDY_DIRECTOR

Tampere University Hospital

Jyrki Ollikainen, MD

Role: PRINCIPAL_INVESTIGATOR

Tampere University Hospital

Kati Järvelä, PhD

Role: STUDY_DIRECTOR

Tampere University Hospital

Valtteri Järvenpää, MB

Role: PRINCIPAL_INVESTIGATOR

Tampere University Hospital

Ville Jalkanen, PhD

Role: STUDY_DIRECTOR

Tampere University Hospital

Joonas Tirkkonen, PhD

Role: STUDY_DIRECTOR

Tampere University Hospital

Heini Huhtala, PhD

Role: STUDY_DIRECTOR

Tampere University

Mika Martiskainen, PhD

Role: STUDY_DIRECTOR

Finnish Institute for Health and Welfare

Riikka Nevalainen, MD

Role: STUDY_DIRECTOR

Tampere University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tampere University hospital

Tampere, , Finland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Finland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sanna Hoppu, PhD

Role: CONTACT

+3583311611

Paula Mäki, MD

Role: CONTACT

+3583311611

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sanna Hoppu, MD, PhD

Role: primary

3583311611

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R18163

Identifier Type: REGISTRY

Identifier Source: secondary_id

R21124

Identifier Type: REGISTRY

Identifier Source: secondary_id

R18100

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.